The Weekly Litigation News Digest is now live. Subscribe now

Pharmaceutical Composition Containing Crystalline Macitentan - EP2988733

The patent EP2988733 was granted to Sandoz on Mar 27, 2019. The application was originally filed on Apr 17, 2014 under application number EP14721256A. The patent is currently recorded with a legal status of "Revoked".

EP2988733

SANDOZ
Application Number
EP14721256A
Filing Date
Apr 17, 2014
Status
Revoked
Sep 16, 2024
Publication Date
Mar 27, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GILL JENNINGS & EVERYDec 23, 2019GILL JENNINGS & EVERYADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2007031933
OTHEREP2988733
OTHERWO2007031933

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents